AUSTIN POPE: Open Payments
NPI 1518630581 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$866 in 40 payments from 13 companies in 2025. Trend: 2023 $392 · 2024 $877 · 2025 $866
Food & beverage: $777Education: $89
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $209 |
| ABBVIE INC. | 10 | $207 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $105 |
| Phathom Pharmaceuticals, Inc. | 3 | $56 |
| GENZYME CORPORATION | 2 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $46 |
| Ardelyx, Inc. | 2 | $37 |
| PFIZER INC. | 2 | $34 |
| Madrigal Pharmaceuticals | 1 | $32 |
| Aimmune Therapeutics, Inc. | 1 | $27 |
Products named: TREMFYA, RINVOQ, EOHILIA, VOQUEZNA, DUPIXENT, XIFAXAN, IBSRELA, XELJANZ.
Industry payments across NC — which companies pay providers there.
